The up-regulation of other proteins, such as Zinc-a-2-glycoprotein, amyloid-A protein and vitamin D-binding protein, was found to play a role in the prediction of a thalidomide response in MM patients [133]. This evidence concerns the gene SAA1 and Miyoshi myopathy.